Day: April 27, 2020

 Bigben                                                                                   Press releaseLesquin, 27 April 2020, 18:00 2019/20 Annual sales up 7.3% to 263.5 M€Impact of the Covid-19 crisis at the end of Q4 2019/20·Q4 2019/20 sales: 51.1 M€ (-13.8%)·New 2019/20 target: Current Operating Profit rate (2) around 9%.Confirmation of targets announced for 2022XXNon audited dataCurrent Operating Margin = Current Operating Income rate = Current Operating Income as a percentage of sales.XActivity impacted by the Covid-19 crisis in the 4th quarterIn the 4th quarter of the 2019/20 financial year (from 1 January to 31 March 2020), business declined by 13.8%, mainly due to the exceptional consequences of the Covid-19 health crisis after five quarters of uninterrupted growth. The decline affected all markets relying on physical points of...

Bigben                                                                                     Communiqué de presseLesquin, 27 avril 2020, 18h00 Chiffre d’affaires annuel 2019/20 en hausse de 7,3 % À 263,5 M€Impact de la crise Covid-19 sur la fin du 4eme trimestre 2019/20·Chiffre d’affaires du 4ème trimestre 2019/20 : 51,1 M€ (-13,8%)·Nouvel Objectif 2019/20 : taux de ROC(2) de l’ordre de 9%.Confirmation des objectifs annoncés pour 2022(1)Données non auditées(2)Marge Opérationnelle Courante = Taux de ROC = Résultat Opérationnel Courant rapporté au chiffre d’affairesUne activité impactée par la crise Covid-19 au 4ème trimestreAu 4ème trimestre de l’exercice 2019/20 (du 1er janvier au 31 mars 2020), l’activité a reculé de 13,8% en raison principalement des conséquences exceptionnelles de la crise sanitaire du Covid-19 après cinq trimestres de...

BEIJING, April 27, 2020 (GLOBE NEWSWIRE) — Kaixin Auto Holdings (“Kaixin” or the “Company”) (NASDAQ: KXIN), one of the primary dealership networks in the premium used car segment in China, today announced the receipt of a notification letter (the “Nasdaq Letter”) dated on April 21, 2020 from the Listing Qualifications department of the Nasdaq Stock Market (“Nasdaq”), notifying Kaixin that, as of April 20, 2020, it failed to meet the requirement of maintaining a minimum bid price of $1 per share pursuant to Nasdaq Rule 5550(a)(2).In accordance with Nasdaq Rule 5810(c)(3)(A), the company has a period of 180 calendar days from the date of the Nasdaq Letter to regain compliance. Compliance can be achieved by having a closing bid price of at least $1.00 for a minimum of 10 consecutive business days during the applicable...

FINANCIAL PRESS RELEASEParis, April 27, 2020Revenue growth for 2019/2020: +6%                                                                                                                                                               Improved EBITDA rate expected for 2019/2020 Generix Group, Industrial, Logistics and Retail Ecosystems provider with leading Collaborative SaaS Solutions issued today its revenues for the 2019/2020 fiscal year.Revenue growth for 2019/2020: +6%With €81.1 million in revenue, the group recorded 6% organic growth over the past fiscal year driven mainly by its dynamic strategic SaaS business (up 14%). Leading growth areas for the financial year were Russia (+60%) and the Iberian Peninsula (+15%), in line with the company’s international deployment strategy. The share of recurring revenue (SaaS & Maintenance)...

COMMUNIQUE FINANCIERParis, le 27 avril 2020Croissance du chiffre d’affaires 2019/2020 : +6%                                                                                                                                       Amélioration du taux d’Ebitda attendue pour l’exercice 2019/2020Generix Group, éditeur de solutions applicatives SaaS pour les écosystèmes industriels, logistiques et du retail, publie aujourd’hui son chiffre d’affaires au titre de l’exercice 2019/2020.Croissance du chiffre d’affaires 2019/2020 : +6%Avec un chiffre d’affaires de 81,1 M€, le groupe affiche sur l’exercice écoulé une croissance organique de 6% portée par le dynamisme de son modèle stratégique SaaS (+14%). Les principales zones de croissance sur l’exercice concernent la Russie (+60%) et la Péninsule Ibérique (+15%), en ligne avec la stratégie de déploiement...

Referat fra FastPassCorp A/S’ ordinære generalforsamling 2020Mandag den 27.april 2020 kl. 16:00Afholdt hos: FastPassCorp A/S og delvist som elektronisk mødeFinn Jensen var opstillet af bestyrelsen som dirigent i henhold til §10.1Finn Jensen konstaterede, at generalforsamlingen var indkaldt i overensstemmelse med vedtægterne og dermed var lovlig. På generalforsamlingen var tilmeldt 554.474 aktier = 65,4%. Personligt eller via fuldmagter var 17 aktionærer repræsenteret.Dagsordeni henhold til vedtægterne:Bestyrelsens beretning om Selskabets virksomhed i det forløbne årBestyrelsesformand Tommy V.Larsen gennemgik hovedpunkterne i Selskabets virksomhed i det forløbne år, i henhold til årsregnskabet.Fremlæggelse af årsrapport og eventuelt koncernårsrapport med revisionspåtegning til godkendelse og descharge til ledelse og bestyrelseSelskabets...

MCLEAN, Va., April 27, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB:FMCC) announced today that it plans to report its first quarter 2020 financial results before the U.S. financial markets open on Thursday, April 30, 2020.The company will hold a conference call at 9 a.m. Eastern Time (ET) on Thursday, April 30, 2020, to discuss the company’s results with the media.  The conference call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days.All materials related to the call will be available on the Investor Relations page of the company’s website.Freddie Mac makes home possible for millions of families and individuals by providing mortgage capital to lenders. Since our creation by Congress in 1970, we’ve made housing more accessible and affordable for homebuyers and renters...

GTT: NOTICE OF AVAILABILITY OF THE 2019 UNIVERSAL REGISTRATION DOCUMENTParis, April 27, 2020 – The 2019 universal registration document of GTT (Gaztransport & Technigaz), a technology and engineering company specialised in the design of membrane containment systems for the transportation and storage of liquefied gas, was registered with the French stock market authorities (AMF) on April 27, 2020.The French version is publicly available free of charge, in accordance with applicable legislation, and may be downloaded from the “Finance” page of the GTT’s website at www.gtt.fr.An English language version of the 2019 universal registration document will soon be available on the GTT’s website.The following documents are included in the 2019 universal registration document:the annual financial report;the management report of the Board...

GTT : MISE A DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2019Saint-Rémy-lès-Chevreuse, le 27 avril 2020 – Le Document d’enregistrement universel 2019 de GTT (Gaztransport & Technigaz), société de technologie et d’ingénierie spécialisée dans la conception de systèmes de confinement à membranes pour le transport et le stockage du gaz liquéfié, a été déposé auprès de l’Autorité des Marchés Financiers le 27 avril 2020. Il est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté et téléchargé à partir du site internet de GTT (www.gtt.fr), au sein de la rubrique « Finance ». Une version anglaise du Document d’enregistrement universel 2019 de GTT sera prochainement disponible sur le site internet de GTT. Les documents suivants sont intégrés dans le Document...

CINCINNATI, April 27, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today the launch of a novel enzyme master mix (Inhibitor Tolerant 1-step RT-qPCR Mix) that eliminates the need to use an RNA extraction kit prior to running the patient sample through a molecular assay.  By eliminating this step, total assay cost is lower and processing times for COVID-19 samples can be reduced by as much as 30 minutes per test. To date, most COVID-19 molecular assays require laboratories to first isolate and purify the SARS-CoV-2 viral RNA from a patient sample (saliva or nasopharyngeal).  This step is not only complex and time consuming, but also adds to the overall cost of the COVID-19 assay.  In addition, RNA sample extraction kits have not been readily available during this pandemic.  To address these shortfalls,...